← SynDRA
PERETINOIN
SynDRA canonical compound SYN0039841 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | RXRA |
|---|
| Mechanism of action | retinoid receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- retinoid receptor agonist
Drug classes
Cross-references
Synonyms
- Nik-333
- Polyprenoic acid
- E-5166
- NIK-333
- Peretinoin (oral)
- Peretinoin (oral), Kowa
- Peretinoin (oral formulation, hepatocellular carcinoma), Kowa Pharmaceutical
- Acyclic retinoid
- 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
- peretinoina
- peretinoine
- peretinoinum
- RefChem:171626
- DTXCID201746653
- Peretinoin [INN]
- E 5166
- MFCD01742209
- NIK333
- Peretinoin (JAN)
- PERETINOIN [JAN]
- 3,7,11,15-tetramethylhexadeca-2,4,6,10,14-pentaenoic acid
- CCRIS 9040
- UNII-11ALM7A4RV
- UUBHZHZSIKRVIV-KCXSXWJSSA-N
- E5166
- PERETINOIN [MART.]
- PERETINOIN [WHO-DD]
- SCHEMBL431954
- orb1296232
- NK-333
- AKOS024463297
- CS-5529
- NCGC00522288-01
- AS-56168
- HY-100008
- C76608
- D06406
- F462890
- BRD-K99431849-001-01-7
Look up PERETINOIN in the interactive SynDRA portal →